Laveta Tablet DT contains Levocetirizine 5mg, a third-generation non-sedative antihistamine used primarily for the relief of allergic symptoms. Levocetirizine is the active enantiomer of cetirizine and acts as a selective antagonist of peripheral H1 histamine receptors, thereby inhibiting the effects of histamine released during allergic reactions. This medication is indicated for the treatment of allergic rhinitis, including seasonal and perennial allergic rhinitis, as well as chronic idiopathic urticaria characterized by itching and hives. Laveta Tablet DT is formulated as a dispersible tablet, allowing for rapid disintegration in the oral cavity without the need for water, enhancing patient compliance, especially in pediatric and geriatric populations. The onset of action is typically within one hour, providing prompt relief from symptoms such as sneezing, nasal congestion, runny nose, and itchy or watery eyes. The recommended dosage is one tablet once daily, with adjustments made based on clinical response and patient tolerance. Levocetirizine is generally well tolerated, with a low incidence of sedation and other adverse effects. Caution is advised in patients with renal impairment, and use during pregnancy or lactation should be under medical supervision. Laveta Tablet DT offers an effective and convenient option for managing allergic conditions.